Hallmark Capital Management Inc Amgen Inc Transaction History

Hallmark Capital Management Inc

$1.32 Billion
Q1 2024

A detailed history of Hallmark Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Hallmark Capital Management Inc holds 82,142 shares of AMGN stock, worth $25.7 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares

82,142

Previous 83,900 2.1%

Holding current value

$25.7 Million

Previous $24.2 Million 3.35%

% of portfolio

1.77%

Previous 1.89%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $472,673 - $570,576	-1,758 Reduced 2.1%	82,142 $23.4 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $215,043 - $242,594	-841 Reduced 0.99%	83,900 $24.2 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $528,039 - $655,575	-2,415 Reduced 2.77%	84,741 $22.8 Million
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $388,471 - $459,359	-1,813 Reduced 2.04%	87,156 $19.4 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $53,963 - $65,772	239 Added 0.27%	88,969 $21.5 Million

Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $810,079 - $1.03 Million	-3,537 Reduced 3.83%	88,730 $23.3 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $210,094 - $236,948	-936 Reduced 1.0%	92,267 $20.8 Million
Q2 2022 Nov 16, 2022	BUY	$230.71 - $256.74 $215,944 - $240,308	936 Added 1.01%	93,203 $22.7 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $468,341 - $521,182	-2,030 Reduced 2.13%	93,203 $22.7 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $611,982 - $677,012	2,791 Added 3.02%	95,233 $23 Million
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $285,989 - $327,288	1,438 Added 1.58%	92,442 $20.8 Million
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $139,249 - $163,147	656 Added 0.73%	91,004 $19.4 Million
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $81,986 - $90,958	-351 Reduced 0.39%	90,348 $22 Million
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $20,415 - $23,791	92 Added 0.1%	90,699 $22.6 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $244,293 - $290,909	1,129 Added 1.26%	90,607 $20.8 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $1.53 Million - $1.7 Million	-6,519 Reduced 6.79%	89,478 $22.7 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $1.5 Million - $1.84 Million	-7,600 Reduced 7.34%	95,997 $22.6 Million
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $905,915 - $1.2 Million	-4,971 Reduced 4.58%	103,597 $21 Million
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $666,776 - $857,036	-3,524 Reduced 3.14%	108,568 $26.2 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $877,514 - $1.05 Million	5,040 Added 4.71%	112,092 $21.7 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $1.55 Million - $1.82 Million	9,327 Added 9.54%	107,052 $19.7 Million
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $443,131 - $499,506	-2,450 Reduced 2.45%	97,725 $18.6 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $395,334 - $461,482	-2,216 Reduced 2.16%	100,175 $19.5 Million
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $217,159 - $244,819	-1,172 Reduced 1.13%	102,391 $21.2 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $39,852 - $44,762	-240 Reduced 0.23%	103,563 $19.1 Million
Q1 2018 Apr 27, 2018	BUY	$169.43 - $198.0 $407,818 - $476,586	2,407 Added 2.37%	103,803 $17.7 Million
Q4 2017 Jan 24, 2018	BUY	$168.79 - $188.59 $1.32 Million - $1.48 Million	7,845 Added 8.39%	101,396 $17.6 Million
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $15.7 Million - $17.9 Million	93,551	93,551 $17.4 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hallmark Capital Management Inc with notifications on news.

Account

Hallmark Capital Management Inc Amgen Inc Transaction History